We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.1%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$336M
AUM Growth
-$79.5M
(-19%)
Cap. Flow
-$67.7M
Cap. Flow
% of AUM
-20.14%
Top 10 Holdings %
Top 10 Hldgs %
21.14%
Holding
166
New
55
Increased
21
Reduced
32
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palomar
PLMR
|
+$6.86M |
| 2 |
Casella Waste Systems
CWST
|
+$6.85M |
| 3 |
Lantheus
LNTH
|
+$5.39M |
| 4 |
MASI
Masimo
MASI
|
+$5.29M |
| 5 |
RBC Bearings
RBC
|
+$5.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$10.4M |
| 2 |
Comfort Systems
FIX
|
+$8.32M |
| 3 |
Freshpet
FRPT
|
+$7.82M |
| 4 |
Kornit Digital
KRNT
|
+$6.62M |
| 5 |
Semtech
SMTC
|
+$6.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.15% |
| 2 | Technology | 20.29% |
| 3 | Industrials | 19.7% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Financials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Revolve Group
RVLV
$1.73B
| – | – |
-100,875
| Closed | -$3.38M |
|
152
Saia
SAIA
$9.72B
| – | – |
-9,160
| Closed | -$4.17M |
|
153
Sweetgreen
SG
$642M
| – | – |
-57,145
| Closed | -$1.83M |
|
154
Shake Shack
SHAK
$2.87B
| – | – |
-25,715
| Closed | -$3.34M |
|
|
155
Semtech
SMTC
$13B
| – | – |
-106,630
| Closed | -$6.6M |
|
156
Sterling Infrastructure
STRL
$16.7B
| – | – |
-21,015
| Closed | -$3.54M |
|
157
Tecnoglass Holdings Inc.
TGLS
$1.96B
| – | – |
-43,595
| Closed | -$3.46M |
|
158
Tandem Diabetes Care
TNDM
$1.53B
| – | – |
-118,550
| Closed | -$4.27M |
|
159
Viking Therapeutics
VKTX
$4B
| – | – |
-43,950
| Closed | -$1.77M |
|
160
Warby Parker
WRBY
$3.25B
| – | – |
-241,840
| Closed | -$5.85M |
|
161
Wolverine World Wide
WWW
$1.55B
| – | – |
-148,050
| Closed | -$3.29M |
|
|
162
Astera Labs
ALAB
$58B
| – | – |
-78,830
| Closed | -$10.4M |
|
163
Loar Holdings
LOAR
$6.64B
| – | – |
-37,976
| Closed | -$2.81M |
|
|
SARO
164
StandardAero Inc
SARO
$9.7B
| – | – |
-69,170
| Closed | -$1.71M |
|
|
ITCI
165
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-72,600
| Closed | -$6.06M |
|
|
NARI
166
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-77,755
| Closed | -$3.97M |
|
Similar funds
PIM
EH
TPWA
VC
IVLAV
BA
FI
GPC
Lisanti Capital Growth's Q1 2025 Portfolio in Review
As of Q1 2025, Lisanti Capital Growth held 166 positions worth $336M, down 19% from $416M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Lisanti Capital Growth withdrew a net $67.7M in Q1 2025, closing 58 positions and reducing 32 holdings. Its most notable exit was Astera Labs, an estimated $10.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
Against the trend, Lisanti Capital Growth opened a new position in Palomar worth $7.93M.
- Lisanti Capital Growth's largest Q1 2025 buy was Palomar: 57,870 shares worth $7.93M.
- Lisanti Capital Growth added most to ANI Pharmaceuticals in Q1 2025, an estimated $4.69M increase.
- Lisanti Capital Growth's biggest Q1 2025 reduction was Xometry, cutting an estimated $4.94M.
- Lisanti Capital Growth fully exited Astera Labs in Q1 2025, selling an estimated $10.4M.
- Lisanti Capital Growth's ten largest holdings make up 21% of its $336M portfolio in Q1 2025.
- Lisanti Capital Growth opened 55 new positions and closed 58 in Q1 2025.
- Lisanti Capital Growth's portfolio value fell 19% quarter-over-quarter to $336M.
Based on Lisanti Capital Growth's 13F filing for Q1 2025, filed 25 Apr 2025.